全文获取类型
收费全文 | 8079篇 |
免费 | 864篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 135篇 |
儿科学 | 232篇 |
妇产科学 | 109篇 |
基础医学 | 1148篇 |
口腔科学 | 316篇 |
临床医学 | 804篇 |
内科学 | 1581篇 |
皮肤病学 | 146篇 |
神经病学 | 585篇 |
特种医学 | 279篇 |
外科学 | 1078篇 |
综合类 | 174篇 |
一般理论 | 10篇 |
预防医学 | 1100篇 |
眼科学 | 267篇 |
药学 | 547篇 |
中国医学 | 10篇 |
肿瘤学 | 425篇 |
出版年
2021年 | 106篇 |
2020年 | 73篇 |
2019年 | 112篇 |
2018年 | 133篇 |
2017年 | 97篇 |
2016年 | 95篇 |
2015年 | 110篇 |
2014年 | 154篇 |
2013年 | 270篇 |
2012年 | 339篇 |
2011年 | 358篇 |
2010年 | 210篇 |
2009年 | 195篇 |
2008年 | 349篇 |
2007年 | 380篇 |
2006年 | 365篇 |
2005年 | 415篇 |
2004年 | 375篇 |
2003年 | 381篇 |
2002年 | 385篇 |
2001年 | 221篇 |
2000年 | 276篇 |
1999年 | 190篇 |
1998年 | 116篇 |
1997年 | 125篇 |
1996年 | 93篇 |
1995年 | 103篇 |
1994年 | 73篇 |
1993年 | 67篇 |
1992年 | 146篇 |
1991年 | 153篇 |
1990年 | 148篇 |
1989年 | 137篇 |
1988年 | 124篇 |
1987年 | 124篇 |
1986年 | 137篇 |
1985年 | 131篇 |
1984年 | 115篇 |
1983年 | 101篇 |
1982年 | 77篇 |
1981年 | 95篇 |
1980年 | 75篇 |
1979年 | 83篇 |
1978年 | 79篇 |
1977年 | 45篇 |
1976年 | 64篇 |
1975年 | 68篇 |
1974年 | 68篇 |
1973年 | 83篇 |
1972年 | 54篇 |
排序方式: 共有8946条查询结果,搜索用时 15 毫秒
11.
Antibiotic prophylaxis and secondary haemorrhage following transurethral resection of the prostate: a prospective trial 总被引:2,自引:0,他引:2
One hundred and sixty-two patients were studied in a random double-blind controlled trial of co-trimoxazole to prevent secondary haemorrhage following transurethral resection of the prostate (TURP). There was a significant correlation between the incidence of post-operative urinary infection and secondary haemorrhage (P less than 0.05) but no difference between the incidence of bleeding in the treatment and placebo groups. Although infection may play a role in the development of secondary haemorrhage, co-trimoxazole for 10 days does not decrease the incidence of this complication. 相似文献
12.
13.
Minor Psychiatric Morbidity, Its Prevalence and Outcome in a Cohort of Civil Servants A Seven-year Follow-up Study 总被引:1,自引:0,他引:1
Jenkins R.; Harvey S.; Butler T.; Lloyd Thomas R. 《Occupational medicine (Oxford, England)》1996,46(3):209-215
During the years 1979–1986, a cohort of direct entrantexecutive officers in the Civil Service were followed up toexamine the prevalence and outcome of minor psychiatric morbidityin an occupational setting. All studies using epidemiologicalstandardized research methods agree, that prevalence rates arehigh in occupational settings. As in primary care settings,half of the illness episodes followed a chronic course, whichemphasizes the need for early detection and prompt managementof these conditions, and for evaluative studies of interventionstrategies. 相似文献
14.
Alan T. Villavicencio MD Lloyd A. Hey MD Dhavalkumar Patel MD PhD Peter Bressler MD 《The Journal of allergy and clinical immunology》1997,100(6):853-854
J Allergy Clin Immunol 1997;100:853-4. 相似文献
15.
16.
17.
H. William Scott Jr. M.D. Craig R. Sussman M.D. David L. Page M.D. Norman W. Thompson M.D. Milton D. Gross M.D. Ricardo Lloyd M.D. 《World journal of surgery》1986,10(4):646-652
Since the syndrome of primary hyperaldosteronism was described by Jerome Conn in 1955, over 300 patients with this disorder have been identified in the medical centers of Vanderbilt University and the University of Michigan. The most frequent cause of this endocrinopathy has been a solitary adenoma of the adrenal cortex (72%); bilateral adrenocortical hyperplasia has been the cause of primary hyperaldosteronism in 27% of cases; less frequently, the cause has been multiple and/or bilateral adenomas (1%). During the last 4 years in these 2 medical centers, we have encountered 3 patients who have had biochemically proven primary hyperaldosteronism due to adrenocortical carcinoma. Each of these unusual cases is summarized with review of the recent literature.
Presented at the International Association of Endocrine Surgeons in Paris, September 1985. 相似文献
Resumen Desde la descripción del síndrome de hiperaldosteronismo primario por Jeremo Conn en 1955, más de 300 pacientes con esta entidad han sido identificados en nuestros 2 centros médicos, la Universidad de Vanderbilt (Nashville) y la Universidad de Michigan (Ann Arbor). La causa más frecuente de esta endocrinopatía ha sido el adenoma solitario de la corteza suprarrenal (72%); la hiperplasia adrenocortical bilateral ha sido la causa del hiperaldosteronismo primario en 27% de los casos; con menor frecuencia se han presentado los adenomas multiples y/o bilaterales (1%). En los 4 últimos años hemos encontrado 3 pacientes con hiperaldosteronismo primario comprobado bioquímicamente producido por carcinoma adrenocortical. Se presenta cada uno de estos casos poco usuales junto con una revisión de la literatura reciente.
Résumé Depuis que le syndrome d'hyperaldostéronisme primitif a été décrit par Jerôme Conn en 1955 plus de 300 sujets qui en étaient victimes ont été identifiés à la Vanderbilt University de Nashville et à l'University of Michigan de Ann Arbor. La cause la plus fréquente de cette endocrinopathie répond à un adénome solitaire de la cortico-surrénale (72%) alors que l'hyperplasie corticale des 2 surrénales est plus rarement à son origine (27%), les adénomes multiples et/ou bilatéraux étant rarissimes (1%). Au cours des 4 dernières années 3 cas d'hyperaldosteronisme dû à un cancer de la cortico-surrénale ont été observés dans les 2 centres. Chacun de ces cas exceptionnels est exposé cependant que la littérature récente concernant l'hyperalderosteronisme est analysée.
Presented at the International Association of Endocrine Surgeons in Paris, September 1985. 相似文献
18.
19.
Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas. 总被引:2,自引:0,他引:2
Onder Onguru Bernd W Scheithauer Kalman Kovacs Sergio Vidal Long Jin Shuya Zhang Katharina H Ruebel Ricardo V Lloyd 《Modern pathology》2004,17(7):772-780
Epidermal growth factor receptor plays an important role in the pathogenesis of many malignancies. Various growth factors, including epidermal growth factor receptor, have been shown to influence pituitary tumor growth and differentiation. To analyze the role of epidermal growth factor receptor in pituitary tumor development, we examined normal pituitaries (n=8), pituitary adenomas (n=158), and pituitary carcinomas (n=7) for expression of epidermal growth factor receptor protein and messenger RNA using tissue microarrays and RT-PCR. We also examined (a) the expression of phospho-epidermal growth factor receptor, the activated form of epidermal growth factor receptor, in pituitary tumors and normal pituitaries by immunohistochemistry and (b) the effects on epidermal growth factor receptor expression of treating pituitary cells (HP75 cell line) with epidermal growth factor. Epidermal growth factor receptor and the phosphorylated variant expression were present in normal pituitary cells. Epidermal growth factor receptor messenger RNA was also detected in normal pituitaries, pituitary adenomas, and carcinomas by in situ hybridization and RT-PCR. Most pituitary adenomas showed expression of epidermal growth factor receptor and the phosphorylated variant. Nonfunctional adenomas showed higher levels of expression of epidermal growth factor receptor (76 vs 34%) and of phospho-epidermal growth factor receptor (26 vs 8%) as compared to functional adenomas. Five of seven pituitary carcinomas showed strong expression of both epidermal growth factor receptor and phospho-epidermal growth factor receptor. When a human pituitary cell line (HP75) was cultured in the presence of epidermal growth factor receptor, there was an increase in the levels of both epidermal growth factor receptor and phospho-epidermal growth factor receptor after 5 h of treatment, thus confirming that epidermal growth factor receptor signaling was active in pituitary tumors. These results indicate that activated epidermal growth factor receptor is expressed in pituitary adenomas and carcinomas. Higher levels in pituitary carcinomas suggest a role in pituitary tumor progression. 相似文献
20.
Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: potentiation of disruption by scopolamine 总被引:1,自引:0,他引:1
A Sahgal A B Keith S Lloyd J M Kerwin E K Perry J A Edwardson 《Pharmacology, biochemistry, and behavior》1990,37(4):597-605
Groups of rats were trained on either delayed matching or nonmatching to position tasks, then divided into four subgroups and given the following bilateral lesions: (a) SHAM [vehicle injection into the nucleus basalis magnocellularis (NBM) and dorsal noradrenergic bundle (DNAB)], (b) DNAB (6-hydroxydopamine lesion of the DNAB, vehicle into the NBM), (c) NBM (quisqualic acid lesion of the NBM, vehicle into the DNAB) and (d) DUAL (neurotoxin lesions of both DNAB and NBM). Following postoperative recovery, the DUAL lesion subjects were slightly impaired, but by the seventh day of testing all groups were performing at similar levels. This strongly suggests that quisqualate lesions of the NBM are not sufficient to produce severe and lasting mnemonic disorders resembling those seen in Alzheimer's disease (AD). These data also indicate that the noradrenergic system may not be of critical importance with respect to cognition. It was reasoned that an additional anticholinergic treatment might exacerbate an underlying deficiency. All groups were injected, peripherally, with the cholinergic antagonist scopolamine (0-0.5 mg/kg). This drug dose-dependently disrupted performance in all groups. Moreover, the highest dose had a marked effect in the DUAL group, impairing performance even when no mnemonic burden was present (at zero delay). The results suggest that cholinergic NBM and noradrenergic DNAB lesions produce only transient mnemonic deficiencies. A combination of the two can be disruptive, but longer term task (or reference) memory is the primary process affected, and only under certain conditions. The implication of these findings to research concerning animal models relating to Alzheimer's disease is discussed. 相似文献